EMEA-003416-PIP01-23 - paediatric investigation plan

irinotecan
PIP Human

Key facts

Invented name
onivyde
Active substance
irinotecan
Therapeutic area
Oncology
Decision number
P/0241/2023
PIP number
EMEA-003416-PIP01-23
Pharmaceutical form(s)
All pharmaceutical forms
Condition(s) / indication(s)
Treatment of pancreatic cancer
Route(s) of administration
All routes of administration
Contact for public enquiries

Les Laboratoires Servier
E-mail: mail.pip.enquiries@servier.com
Tel.: +33 155726000

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page